Enovis Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ENOV | CNMD | BVS | KIDS | IART | OFIX | |
|---|---|---|---|---|---|---|
| Market cap | 1.05B | 1.36B | 924.17M | 576.50M | 1.09B | 375.11M |
| P/E (TTM) | — | 24.5 | 17.3 | — | — | — |
| Forward P/E | 5.1 | 9.5 | 14.7 | -31.1 | 5.4 | 25.1 |
| Price/book | 0.7 | 1.3 | 4.0 | 1.7 | 1.0 | 0.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −40.50% | +2.35% | +98.86% | +23.64% | −1.32% | −36.76% |
| Today | +3.17% | +2.12% | +3.56% | +1.99% | +4.02% | +1.20% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All ENOV news ›Enovis (NYSE:ENOV) and electroCore (NASDAQ:ECOR) Head to Head Survey
Posted by Kim Johansen on Oct 11th, 2026 Enovis (NYSE:ENOV – Get Free Report) and electroCore (NASDAQ:ECOR – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based…
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
Enovis (NYSE: ENOV) will host a conference call to discuss third-quarter 2026 financial results on November 5, 2026. Enovis (NYSE: ENOV) will host a conference call to discuss third-quarter 2026 financial results on November 5, 2026. The…
Enovis officer buys 7,598 shares in open market
Chief administrative officer Oliver Engert bought 7,598 Enovis shares on Sept. 2–3, 2026 at $20.32 and $19.46 in open-market trades, per a Form 4. Enovis officer buys 7,598 shares in open market Enovis CORP (ENOV) reported that Chief…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
stocktitan.net1
-
themarketsdaily.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.